The PANDORA study: Peripheral arterial disease in patients with non-high cardiovascular risk

Internal and Emergency Medicine

Volumn 6, Issue 6, 2011, Pages 509-519

  Cimminiello, Claudio ^a   Kownator, Serge ^b   Wautrecht, Jean Claude ^c   Carvounis, Christos P ^d   Kranendonk, Stefanus Eliza ^e   Kindler, Beat ^f   Mangrella, Mario ^g   Borghi, Claudio ^h  

^a DESIO HOSPITAL   (Italy)

^b Clinique Ambroise Paré   (France)

^c ERASME HOSPITAL   (Belgium)

^d Internal Medicine Department   (Greece)

^e CPRLab   (Netherlands)

^f AstraZeneca SpA ^*  (Switzerland)

^g ASTRAZENECA   (United Kingdom)

^h UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Ankle brachial index; Atherosclerosis; Peripheral vascular disease; Prevention; Risk factors

Indexed keywords

EID: 82155188949     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0511-0     Document Type: Article

References (39)

1. Kannel WB, Skinner JJ Jr, Schwartz MJ, Shurtleff D (1970) Intermittent claudication: incidence in the Framingham Study. Circulation 41: 875-883.
2. Stoffers HEJH, Kester ADM, Kaiser V, Rinkens PELM, Kitslaar PJEHM, Knottnerus AJ (1996) The diagnostic value of the measurement of the ankle-brachial systolic pressure index in primary health care. J Clin Epidemiol 49: 1401-1405.
3. Reunanen A, Takkunen H, Aromaa A (1982) Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand 211: 249-256.
4. Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I (1978) Intermittent claudication: factors determining outcome. Br Med J 1: 1377-1379.
5. Leng GC, Lee AJ, Fowkes FGR et al (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25: 1172-1181.
6. Hooi JD, Kester AD, Stoffers HE, Rinkens PE, Knottnerus JA, van Ree JW (2004) Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol 57: 294-300.
7. Criqui MH, Langer RD, Fronek A et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381-386.
8. Hirsch AT, Haskal ZJ, Hertzer NR et al (2006) ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113: e463-e654.
9. Norgren L, Hiatt WR, Dormandy JA et al (2007) TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 26: 81-157.
10. Graham I, Atar D, Borch-Johnsen K et al (2007) European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14(Suppl 2): S1-S113.
11. Fowkes FG, Murray GD, Butcher I, for the Ankle Brachial Index Collaboration et al (2008) Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300: 197-208.
12. Beckman JA, Jaff MR, Creager MA (2006) The United States Preventive Services Task Force Recommendation Statement on screening for peripheral arterial disease: more harm than benefit? Circulation 114: 861-866.
13. Diehm C, Allenberg JR, Pittrow D, for the German Epidemiological Trial on Ankle Brachial Index Study Group et al (2009) Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120: 2053-2061.
14. Grundy SM, Cleeman JI, Merz CN et al (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110: 227-239.
15. Cimminiello C, Borghi C, Kownator S et al (2010) Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study. BMC Cardiovasc Disord 10: 35-40.
16. Hiatt WR, Goldstone J, Smithe SC et al (2008) Atherosclerotic peripheral vascular disease symposium II: nomenclature for vascular diseases. Circulation 118: 2826-2829.
17. Wilson PW, Castelli WP, Kannel WB (1987) Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 59: 91G-94G.
18. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100: 1481-1492.
19. Conroy RM, Pyörälä K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. SCORE project group. Eur Heart J 11: 987-1003.
20. Fowkes FGR, Low LP, Tuta S, Kozak J, on behalf of the AGATHA Investigators (2006) Ankle-brachial index and extent of atherothrombosis in 8891 subjects with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J 27: 1861-1867.
21. Hirsch AT, Criqui MH, Treat-Jacobson D et al (2001) Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286: 1317-1324.
22. McDermott MM, Guralnik JM, Tian L et al (2009) Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol 53: 1056-1062.
23. Resnick HE, Lindsay RS, McDermott MM et al (2004) Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109: 733-739.
24. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB (2006) Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 113: 388-393.
25. getABI Study Group (2002) German epidemiological trial on ankle brachial index for elderly patients in family practice to detect peripheral arterial disease, significant marker for high mortality. Vasa 31: 241-248.
26. Diehm C, Schuster A, Allenberg JR et al (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172: 95-105.
27. Dhangana R, Murphy TP, Pencina MJ, Ristuccia MB, Cereo JV, Tsai D (2009) Prevalence of low ankle-brachial index, elevated plasma fibrinogen and CRP among those otherwise at low-intermediate cardiovascular events' risk: data from the National Health and Nutrition Examination Study (NHANES) 1999-2004. J Vasc Interv Radiol 20(suppl 2): S57.
28. Zimmerman BR, Palumbo PJ, Fallon WM, Ellefson RD, Osmundson PJ, Kazmier FJ (1981) A prospective study of peripheral occlusive arterial disease in diabetes, III: initial lipid and lipoprotein findings. Mayo Clinic Proc 56: 233-242.
29. Murabito JM, D'Agostino RB, Silbershatz H et al (1997) Intermittent claudication. A risk profile from the Framingham Heart Study. Circulation 96: 44-49.
30. Heart Protection Study Collaborative Group (2007) Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20, 536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 45: 645-654.
31. Pedersen TR, Kjekshus J, Pyörälä K et al (1998) Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol 81: 333-335.
32. Giri J, McDermott MM, Greenland P et al (2006) Statin use and functional decline in patients with and without peripheral arterial disease. J Am Coll Cardiol 47: 998-1004.
33. Oka RK, Szuba A, Giacomini JC, Cooke JP (2004) Predictors of physical function in patients with peripheral arterial disease and claudication. Prog Cardiovasc Nurs 19: 89-94.
34. Rosengren A, Hawken S, Ounpuu S, for the INTERHEART investigators et al (2004) Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364: 953-962.
35. McDermott MM (1999) Ankle brachial index as a predictor of outcomes in peripheral arterial disease. J Lab Clin Med 133: 33-40.
36. Heald CL, Fowkes FG, Murray GD, Price JF (2006) Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Ankle Brachial Index Collaboration. Atherosclerosis 189: 61-69.
37. Reed JF 3rd, Eid S, Edris B, Sumner AD (2009) Prevalence of peripheral arterial disease varies significantly depending upon the method of calculating ankle brachial index. Eur J Cardiovasc Prev Rehabil 16: 377-381.
38. Cacoub P, Cambou JP, Kownator S et al (2009) Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract 63: 63-70.
39. Diehm C, Lange S, Darius H et al (2006) Association of low ankle brachial index with high mortality in primary care. Eur Heart J 27: 1743-1749.